Human Gene PIK3C2A (ENST00000691414.1_3) from GENCODE V47lift37
  Description: phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha, transcript variant 1 (from RefSeq NM_002645.4)
Gencode Transcript: ENST00000691414.1_3
Gencode Gene: ENSG00000011405.14_10
Transcript (Including UTRs)
   Position: hg19 chr11:17,108,122-17,229,533 Size: 121,412 Total Exon Count: 33 Strand: -
Coding Region
   Position: hg19 chr11:17,111,285-17,191,288 Size: 80,004 Coding Exon Count: 32 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:17,108,122-17,229,533)mRNA (may differ from genome)Protein (1686 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: P3C2A_HUMAN
DESCRIPTION: RecName: Full=Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha; Short=PI3K-C2-alpha; Short=PtdIns-3-kinase C2 subunit alpha; EC=2.7.1.154; AltName: Full=Phosphoinositide 3-kinase-C2-alpha;
FUNCTION: Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers. Has a role in several intracellular trafficking events. Functions in insulin signaling and secretion. Required for translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane and glucose uptake in response to insulin- mediated RHOQ activation. Regulates insulin secretion through two different mechanisms: involved in glucose-induced insulin secretion downstream of insulin receptor in a pathway that involves AKT1 activation and TBC1D4/AS160 phosphorylation, and participates in the late step of insulin granule exocytosis probably in insulin granule fusion. Synthesizes PtdIns3P in response to insulin signaling. Functions in clathrin-coated endocytic vesicle formation and distribution. Regulates dynamin- independent endocytosis, probably by recruiting EEA1 to internalizing vesicles. In neurosecretory cells synthesizes PtdIns3P on large dense core vesicles. Participates in calcium induced contraction of vascular smooth muscle by regulating myosin light chain (MLC) phosphorylation through a mechanism involving Rho kinase-dependent phosphorylation of the MLCP-regulatory subunit MYPT1. May play a role in the EGF signaling cascade. May be involved in mitosis and UV-induced damage response. Required for maintenance of normal renal structure and function by supporting normal podocyte function.
CATALYTIC ACTIVITY: ATP + 1-phosphatidyl-1D-myo-inositol 4- phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate.
COFACTOR: Calcium or magnesium. Manganese cannot be used.
ENZYME REGULATION: Activated by insulin (By similarity). Only slightly inhibited by wortmannin and LY294002. Activated by clathrin.
BIOPHYSICOCHEMICAL PROPERTIES: Kinetic parameters: KM=122 uM for PtdIns (in the absence of phosphatidylserine); KM=64 uM for PtdIns (in the presence of phosphatidylserine); KM=25 uM for PtdIns4P (in the presence of phosphatidylserine); KM=15 uM for ATP (with PtdIns as substrate) (in the absence of phosphatidylserine); KM=32 uM for ATP (with PtdIns as substrate) (in the presence of phosphatidylserine); KM=54 uM for ATP (with PtdIns4P as substrate) (in the presence of phosphatidylserine); Vmax=990 pmol/min/mg enzyme with PtdIns as substrate (in the absence of phosphatidylserine); Vmax=200 pmol/min/mg enzyme with PtdIns as substrate (in the presence of phosphatidylserine); Vmax=240 pmol/min/mg enzyme with PtdIns4P as substrate (in the presence of phosphatidylserine); Vmax=6800 pmol/min/mg enzyme toward ATP with PtdIns as substrate (in the absence of phosphatidylserine); Vmax=805 pmol/min/mg enzyme toward ATP with PtdIns as substrate (in the presence of phosphatidylserine); Vmax=880 pmol/min/mg enzyme toward ATP with PtdIns4P as substrate (in the presence of phosphatidylserine); Note=In the absence of the carrier phosphatidylserine, enzymatic kinetics toward PtdIns4P are non-linear;
SUBUNIT: Part of a complex with ERBB2 and EGFR. Interacts with clathrin trimers.
SUBCELLULAR LOCATION: Cell membrane. Golgi apparatus. Cytoplasmic vesicle, clathrin-coated vesicle. Nucleus. Cytoplasm. Note=According to PubMed:10766823 and PubMed:11239472, it is found in the cell membrane, the Golgi apparatus and in clathrin-coated vesicles. According to PubMed:17038310 it inserts preferentially into membranes containing PtdIns(4,5)P2. According to PubMed:11606566, it is nuclear and cytoplasmic. Associated with RNA-containing structures. According to PubMed:14563213, it is mainly cytoplasmic.
TISSUE SPECIFICITY: Expressed in columnar and transitional epithelia, mononuclear cells, smooth muscle cells, and endothelial cells lining capillaries and small venules (at protein level). Ubiquitously expressed, with highest levels in heart, placenta and ovary, and lowest levels in the kidney. Detected at low levels in islets of Langerhans from type 2 diabetes mellitus individuals.
PTM: Phosphorylated upon insulin stimulation; which may lead to enzyme activation (By similarity). Phosphorylated on Ser-259 during mitosis and upon UV irradiation; which does not change enzymatic activity but leads to proteasomal degradation. Ser-259 phosphorylation may be mediated by CDK1 or JNK, depending on the physiological state of the cell.
SIMILARITY: Belongs to the PI3/PI4-kinase family.
SIMILARITY: Contains 1 C2 domain.
SIMILARITY: Contains 1 C2 PI3K-type domain.
SIMILARITY: Contains 1 PI3K-RBD domain.
SIMILARITY: Contains 1 PI3K/PI4K domain.
SIMILARITY: Contains 1 PIK helical domain.
SIMILARITY: Contains 1 PX (phox homology) domain.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: PIK3C2A
Diseases sorted by gene-association score: acute kidney failure (31), status asthmaticus (30), leptospirosis (28), neuroleptic malignant syndrome (26), inferior myocardial infarction (25), ornithosis (22), myositis (20), acute myocardial infarction (18), crimean-congo hemorrhagic fever (17), legionnaires' disease (16), dermatomyositis (15), pericardial effusion (15), toxic myocarditis (15), posteroinferior myocardial infarction (15), acute anterolateral myocardial infarction (15), trichostrongylosis (15), polymyositis (14), trichostrongyloidiasis (14), compartment syndrome (13), ectopic pregnancy (13), dysphagia (12), cardiogenic shock (12), metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration (12), trichinosis (11), lateral myocardial infarction (11), tick paralysis (11), posterior myocardial infarction (11), vibrio vulnificus infection (10), creatine phosphokinase, elevated serum (10), nephropathia epidemica (10), gas gangrene (9), malignant hyperthermia (9), virus associated hemophagocytic syndrome (9), autoimmune hypoparathyroidism (9), scleromyxedema (9), granulomatous myositis (8), myoglobinuria (8), acute mountain sickness (8), bacterial meningitis (8), erysipelas (8), disseminated intravascular coagulation (7), apparent mineralocorticoid excess (7), anterior compartment syndrome (7), endocarditis (7), duchenne muscular dystrophy (7), myositis fibrosa (7), quadriplegia (7), diabetes mellitus, ketosis-prone (7), respiratory failure (7), polycystic kidney disease 4, with or without hepatic disease (7), myocardial infarction (7), anteroseptal myocardial infarction (7), interstitial myocarditis (6), pulmonary edema (6), dengue disease (6), pericardium disease (6), distal muscular dystrophy (6), tricuspid valve prolapse (6), sarcocystosis (6), fiedler's myocarditis (6), cardiac arrest (6), atrioventricular block (5), coronary artery disease (5), asphyxia neonatorum (5), proliferative fasciitis (5), chromosome xp21 deletion syndrome (5), plexopathy (5), cryptogenic organizing pneumonia (5), intermediate coronary syndrome (5), muscle disorders (5), anuria (5), extrinsic cardiomyopathy (5), pseudohyperkalemia, familial, 2, due to red cell leak (5), diaphragmatic eventration (4), functional diarrhea (4), pneumonia (4), transverse colon cancer (4), ventricular tachycardia, catecholaminergic polymorphic, 1 (4), congestive heart failure (4), heart disease (3), myopathy (3), muscle tissue disease (2)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -74.50204-0.365 Picture PostScript Text
3' UTR -732.503163-0.232 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR016024 - ARM-type_fold
IPR000008 - C2_Ca-dep
IPR008973 - C2_Ca/lipid-bd_dom_CaLB
IPR018029 - C2_membr_targeting
IPR011009 - Kinase-like_dom
IPR001683 - Phox
IPR000403 - PI3/4_kinase_cat_dom
IPR018936 - PI3/4_kinase_CS
IPR002420 - PI3K_C2_dom
IPR000341 - PI3K_Ras-bd_dom
IPR015433 - PI_Kinase
IPR001263 - PInositide-3_kin_accessory_dom

Pfam Domains:
PF00168 - C2 domain
PF00454 - Phosphatidylinositol 3- and 4-kinase
PF00613 - Phosphoinositide 3-kinase family, accessory domain (PIK domain)
PF00787 - PX domain
PF00792 - Phosphoinositide 3-kinase C2
PF00794 - PI3-kinase family, ras-binding domain

SCOP Domains:
48371 - ARM repeat
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
56112 - Protein kinase-like (PK-like)
54236 - Ubiquitin-like
64268 - PX domain

Protein Data Bank (PDB) 3-D Structure
MuPIT help
2AR5 - X-ray MuPIT 2IWL - X-ray MuPIT 2REA - X-ray MuPIT 2RED - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on O00443
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologGenome BrowserNo ortholog
Gene DetailsGene Details Gene DetailsGene Details 
Gene SorterGene Sorter Gene SorterGene Sorter 
 RGDEnsembl WormBase 
    Protein Sequence 
    Alignment 

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0000166 nucleotide binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016303 1-phosphatidylinositol-3-kinase activity
GO:0016740 transferase activity
GO:0035004 phosphatidylinositol 3-kinase activity
GO:0035005 1-phosphatidylinositol-4-phosphate 3-kinase activity
GO:0035091 phosphatidylinositol binding

Biological Process:
GO:0006661 phosphatidylinositol biosynthetic process
GO:0006887 exocytosis
GO:0006897 endocytosis
GO:0007173 epidermal growth factor receptor signaling pathway
GO:0008286 insulin receptor signaling pathway
GO:0014065 phosphatidylinositol 3-kinase signaling
GO:0014829 vascular smooth muscle contraction
GO:0016310 phosphorylation
GO:0016477 cell migration
GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process
GO:0046854 phosphatidylinositol phosphorylation
GO:0048008 platelet-derived growth factor receptor signaling pathway
GO:0048015 phosphatidylinositol-mediated signaling
GO:0048268 clathrin coat assembly
GO:0061024 membrane organization
GO:0090050 positive regulation of cell migration involved in sprouting angiogenesis

Cellular Component:
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005794 Golgi apparatus
GO:0005829 cytosol
GO:0005886 plasma membrane
GO:0005942 phosphatidylinositol 3-kinase complex
GO:0016020 membrane
GO:0030136 clathrin-coated vesicle
GO:0031410 cytoplasmic vesicle
GO:0031982 vesicle
GO:0070062 extracellular exosome


-  Descriptions from all associated GenBank mRNAs
  AK309610 - Homo sapiens cDNA, FLJ99651.
AK304262 - Homo sapiens cDNA FLJ61072 complete cds, highly similar to Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide (EC 2.7.1.154).
AK294416 - Homo sapiens cDNA FLJ53905 complete cds, highly similar to Phosphatidylinositol-4-phosphate 3-kinase C2domain-containing alpha polypeptide (EC 2.7.1.154).
BC113658 - Homo sapiens phosphoinositide-3-kinase, class 2, alpha polypeptide, mRNA (cDNA clone MGC:142218 IMAGE:8322710), complete cds.
Y13367 - H.sapiens mRNA for phosphoinositide 3-kinase.
HQ258691 - Synthetic construct Homo sapiens clone IMAGE:100072721 phosphoinositide-3-kinase, class 2, alpha polypeptide (PIK3C2A) gene, encodes complete protein.
AB385161 - Synthetic construct DNA, clone: pF1KB6002, Homo sapiens PIK3C2A gene for phosphoinositide-3-kinase, class 2, alpha polypeptide, complete cds, without stop codon, in Flexi system.
AK299474 - Homo sapiens cDNA FLJ60339 complete cds, highly similar to Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha polypeptide (EC 2.7.1.154).
AK310248 - Homo sapiens cDNA, FLJ17290.
BC040952 - Homo sapiens phosphoinositide-3-kinase, class 2, alpha polypeptide, mRNA (cDNA clone IMAGE:5179260), with apparent retained intron.
BC031681 - Homo sapiens phosphoinositide-3-kinase, class 2, alpha polypeptide, mRNA (cDNA clone IMAGE:5163654), with apparent retained intron.
AL049998 - Homo sapiens mRNA; cDNA DKFZp564L222 (from clone DKFZp564L222).
BX648778 - Homo sapiens mRNA; cDNA DKFZp686L193 (from clone DKFZp686L193).
AL832699 - Homo sapiens mRNA; cDNA DKFZp313L1834 (from clone DKFZp313L1834).
JD269660 - Sequence 250684 from Patent EP1572962.
JD354050 - Sequence 335074 from Patent EP1572962.
JD387788 - Sequence 368812 from Patent EP1572962.
JD543497 - Sequence 524521 from Patent EP1572962.
JD543498 - Sequence 524522 from Patent EP1572962.
JD497877 - Sequence 478901 from Patent EP1572962.
CR627335 - Homo sapiens mRNA; cDNA DKFZp686B21128 (from clone DKFZp686B21128).
HV544055 - JP 2011217667-A/6: Non-human knockout animal, and use and production method thereof.
BC035982 - Homo sapiens, clone IMAGE:4613935, mRNA.

-  Biochemical and Signaling Pathways
  BioCyc Knowledge Library
PWY-6352 - 3-phosphoinositide biosynthesis
PWY-6371 - superpathway of inositol phosphate compounds

Reactome (by CSHL, EBI, and GO)

Protein O00443 (Reactome details) participates in the following event(s):

R-HSA-8868071 Clathrin recruits PIK3C2A
R-HSA-8867754 F- and N- BAR domain proteins bind the clathrin-coated pit
R-HSA-421833 Vamp And trans-Golgi Network AP-1 Binding Coupled With Cargo Capture
R-HSA-421836 trans-Golgi Network Derived Vesicle Uncoating
R-HSA-421831 trans-Golgi Network Coat Assembly
R-HSA-421835 trans-Golgi Network Vesicle Scission
R-HSA-1676206 PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A at the early endosome membrane
R-HSA-8868072 Clathrin-associated PIK3C2A phosphorylates PI(4)P to PI(3,4)P2
R-HSA-1675939 PI is phosphorylated to PI3P by PIK3C2A/3 at the early endosome membrane
R-HSA-1675961 PI is phosphorylated to PI3P by PIK3C2A/3 at the Golgi membrane
R-HSA-1676024 PI is phosphorylated to PI3P by PIK3C2A/3 at the late endosome membrane
R-HSA-1676109 PI4P is phosphorylated to PI(3,4)P2 by PI3K3C[2] at the plasma membrane
R-HSA-1675928 PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A/G at the Golgi membrane
R-HSA-8856828 Clathrin-mediated endocytosis
R-HSA-432722 Golgi Associated Vesicle Biogenesis
R-HSA-199991 Membrane Trafficking
R-HSA-421837 Clathrin derived vesicle budding
R-HSA-1660516 Synthesis of PIPs at the early endosome membrane
R-HSA-5653656 Vesicle-mediated transport
R-HSA-199992 trans-Golgi Network Vesicle Budding
R-HSA-1660514 Synthesis of PIPs at the Golgi membrane
R-HSA-1660517 Synthesis of PIPs at the late endosome membrane
R-HSA-1660499 Synthesis of PIPs at the plasma membrane
R-HSA-1483255 PI Metabolism
R-HSA-1483257 Phospholipid metabolism
R-HSA-556833 Metabolism of lipids
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: B0LPH2, B4E2G4, NM_002645, O00443, P3C2A_HUMAN, Q14CQ9, uc330vyl.1, uc330vyl.2
UCSC ID: ENST00000691414.1_3
RefSeq Accession: NM_002645.4
Protein: O00443 (aka P3C2A_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.